Adcytherix
PrivateLast Round
Series A
Oct 16, 2025
Total Funding Raised
$154.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Adcytherix is a biopharmaceutical company that develops novel antibody-drug conjugates (ADCs) for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adcytherix Comparables
Compare Adcytherix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sidewinder | 78% | |
| Lonza Group | 77% | |
| TRIO Pharmaceuticals, Inc. | 77% | |
Adcytherix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 16, 2025 | ||||
| Seed | Jun 11, 2024 |
Key People
Founding team and executive leadership
Adcytherix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series A |
| RA Capital Management | Series A, Seed |
| Andera Partners | Series A |
| Pontifax Venture Capital | Series A, Seed |
| Dawn Biopharma | Series A |
| aMoon | Series A |
| Dawn Biopharma | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Grew 50% QoQ, from 16 to 24 employees.
- Mar 1, 2026
Simon Sturge appointed to reinforce governance during clinical growth phase.
Adcytherix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adcytherix's valuation, stock price, and market status.